Real-world data and clinical experience from over 100,000 multi-cancer early detection tests

Nature·Oct 31

This story is reported by Nature. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

Ochsner research leads groundbreaking findings for Multi-Cancer Early Detection (MCED)

Ochsner Health·Jan 9

2

Early detection of multiple cancers: the era of methylation-based liquid biopsy

Frontiers·Jun 8

3

GRAIL to Share Real-World Data from 100,000 Galleri Multi-Cancer Detection Tests at 2025 AACR Meeting

Patient Care Online·Apr 23

4

Prioritizing potentially cancer-causing mutations in real-world cancer genomics

Medical Xpress·Mar 31

5

EvoMDT: a self-evolving multi-agent system for structured clinical decision-making in multi-cancer

Nature·Jan 7

6

GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting

PR Newswire·Apr 22

7

Transforming the future of stroke care: Philips supports stroke pathway redesign at Royal London Hospital

Philips·Dec 18

8

GRAIL’s woes raise questions about the prospects of MCDs and standards for their evaluation

The Cancer Letter·Oct 25